EP 2001454 A2 20081217 - USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS
Title (en)
USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS
Title (de)
VERWENDUNG VON MINDESTENS EINEM CYTOSOL-PHOSPHOLIPASE-A2-HEMMERS ALS MEDIKAMENT ZUR SYMPTOMATISCHEN BEHANDLUNG VON MUKOVISZIDOSE
Title (fr)
UTILISATION D'AU MOINS UN INHIBITEUR DE LA PHOSPHOLIPASE A2 CYTOSOLIQUE COMME MÉDICAMENT POUR LE TRAITEMENT SYMPTOMATIQUE DE LA MUCOVISCIDOSE
Publication
Application
Priority
- FR 2007000582 W 20070405
- FR 0603059 A 20060406
Abstract (en)
[origin: WO2007118996A2] The purpose of this invention is the use of at least one cytosolic phospholipase A2 (cPLA2) inhibitor in the preparation of a medicine intended for preventive and/or remedial symptomatic treatment of mucoviscidosis, and particularly the increased secretion of mucus in mucoviscidosis.
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/12 (2006.01); A61K 31/121 (2006.01); A61K 31/40 (2006.01); A61K 31/404 (2006.01); A61K 31/43 (2006.01); A61K 31/661 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01)
CPC (source: EP US)
A61K 31/00 (2013.01 - EP US); A61K 31/12 (2013.01 - EP US); A61K 31/121 (2013.01 - EP US); A61K 31/40 (2013.01 - EP US); A61K 31/404 (2013.01 - EP US); A61K 31/43 (2013.01 - EP US); A61K 31/46 (2013.01 - EP US); A61K 31/661 (2013.01 - EP US); A61K 31/7105 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2007118996A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2899471 A1 20071012; CA 2648239 A1 20071025; EP 2001454 A2 20081217; JP 2009532445 A 20090910; US 2010093985 A1 20100415; WO 2007118996 A2 20071025; WO 2007118996 A3 20080410
DOCDB simple family (application)
FR 0603059 A 20060406; CA 2648239 A 20070405; EP 07731257 A 20070405; FR 2007000582 W 20070405; JP 2009503616 A 20070405; US 29596507 A 20070405